AAAAAA

   
Results: 1-12 |
Results: 12
PENETRATION OF TACRINE INTO CEREBROSPINAL-FLUID IN PATIENTS WITH ALZHEIMERS-DISEASE
Authors: GROTHE DR PISCITELLI SC DUKOFF R FULLERTON T SUNDERLAND T MOLCHAN SE
Citation: Dr. Grothe et al., PENETRATION OF TACRINE INTO CEREBROSPINAL-FLUID IN PATIENTS WITH ALZHEIMERS-DISEASE, Journal of clinical psychopharmacology, 18(1), 1998, pp. 78-81
ACUTE STROKE MANAGEMENT - REDUCING RESPONSE-TIMES THAT RELAY STROKE TREATMENT
Authors: TINKELMAN BJ BATES VE FULLERTON T KOMOROWSKI D
Citation: Bj. Tinkelman et al., ACUTE STROKE MANAGEMENT - REDUCING RESPONSE-TIMES THAT RELAY STROKE TREATMENT, Neurology, 48(3), 1997, pp. 5017-5017
PHARMACODYNAMICS (PD) OF SUMATRIPTAN(S) IN NITROGLYCERIN (NTG) INDUCED HEADACHE (HA)
Authors: KOMOROWSKI D FULLERTON T FORREST A GENGO FM
Citation: D. Komorowski et al., PHARMACODYNAMICS (PD) OF SUMATRIPTAN(S) IN NITROGLYCERIN (NTG) INDUCED HEADACHE (HA), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 18-18
POPULATION PHARMACODYNAMICS (PD) OF CABERGOLINE (CAB), IN PATIENTS WITH PARKINSONS-DISEASE
Authors: FULLERTON T FORREST A COLLINS DA NARANG PK
Citation: T. Fullerton et al., POPULATION PHARMACODYNAMICS (PD) OF CABERGOLINE (CAB), IN PATIENTS WITH PARKINSONS-DISEASE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 72-72
COMPARISON OF ORTHOGONAL AND NONORTHOGONAL METHODS FOR MODELING CONCENTRATION-EFFECT (C-E) DATA
Authors: SHORE RM FULLERTON T FORREST A
Citation: Rm. Shore et al., COMPARISON OF ORTHOGONAL AND NONORTHOGONAL METHODS FOR MODELING CONCENTRATION-EFFECT (C-E) DATA, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 97-97
PHARMACODYNAMIC (PD) ANALYSIS OF SPARSE DATA FROM CONCENTRATION (CCT)-CONTROLLED AND EFFECT-CONTROLLED (ECT) CLINICAL-TRIALS, GUIDED BY A PILOT-STUDY
Authors: FULLERTON T FORREST A LEVY G
Citation: T. Fullerton et al., PHARMACODYNAMIC (PD) ANALYSIS OF SPARSE DATA FROM CONCENTRATION (CCT)-CONTROLLED AND EFFECT-CONTROLLED (ECT) CLINICAL-TRIALS, GUIDED BY A PILOT-STUDY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 190-190
PHARMACODYNAMICS (PD) OF NITROGLYCERIN (NTG) HEADACHE (HA)
Authors: FULLERTON T GENGO FM TEGELER CH DAVIDAI G FOX A
Citation: T. Fullerton et al., PHARMACODYNAMICS (PD) OF NITROGLYCERIN (NTG) HEADACHE (HA), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 203-203
LEVODOPA PHARMACODYNAMICS
Authors: FULLERTON T
Citation: T. Fullerton, LEVODOPA PHARMACODYNAMICS, Neurology, 44(2), 1994, pp. 365-366
EFFECTS OF ACETAMINOPHEN (APAP) AND IBUPROFEN (IBU) ON THE ANTIPLATETLET ACTIONS OF SINGLE-DOSE ACETYLSALICYLIC-ACID (ASA)
Authors: FULLERTON T MCKINNON P GENGO F
Citation: T. Fullerton et al., EFFECTS OF ACETAMINOPHEN (APAP) AND IBUPROFEN (IBU) ON THE ANTIPLATETLET ACTIONS OF SINGLE-DOSE ACETYLSALICYLIC-ACID (ASA), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 202-202
OCULOGYRIC CRISIS POSSIBLY RELATED TO PENTAZOCINE
Authors: BURSTEIN AH FULLERTON T
Citation: Ah. Burstein et T. Fullerton, OCULOGYRIC CRISIS POSSIBLY RELATED TO PENTAZOCINE, The Annals of pharmacotherapy, 27(7-8), 1993, pp. 874-876
FOCUS ON RESEARCH-AND-DEVELOPMENT - IN NEW-ZEALAND
Authors: FULLERTON T
Citation: T. Fullerton, FOCUS ON RESEARCH-AND-DEVELOPMENT - IN NEW-ZEALAND, Appita journal, 46(6), 1993, pp. 402-403
EVALUATION OF THE RENAL PROTECTIVE EFFECT OF MISOPROSTOL IN ELDERLY, OSTEOARTHRITIC PATIENTS AT RISK FOR NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED RENAL DYSFUNCTION
Authors: FULLERTON T SICA DA BLUM RA
Citation: T. Fullerton et al., EVALUATION OF THE RENAL PROTECTIVE EFFECT OF MISOPROSTOL IN ELDERLY, OSTEOARTHRITIC PATIENTS AT RISK FOR NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED RENAL DYSFUNCTION, Journal of clinical pharmacology, 33(12), 1993, pp. 1225-1232
Risultati: 1-12 |